IBS-D (diarrhea-predominant)

Clinical trials for IBS-D (diarrhea-predominant) explained in plain language.

Never miss a new study

Get alerted when new IBS-D (diarrhea-predominant) trials appear

Sign up with your email to follow new studies for IBS-D (diarrhea-predominant), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 2 Not yet recruiting 1 Completed 1

New drug trial aims to calm IBS-Related diarrhea and pain

Symptom relief Not yet recruiting

This study tests whether ramosetron, a drug that affects gut serotonin, can improve symptoms in people with diarrhea-predominant IBS. Seventy-six adults aged 18–65 will receive either ramosetron or a placebo daily for four weeks, along with a low-FODMAP diet and lifestyle advice.…

Matched conditions: IBS-D (DIARRHEA-PREDOMINANT)

Phase 4 • Sponsor: Md. Aminul Islam • Aim: Symptom relief

Last updated Jun 27, 2026 12:31 UTC

IBS-D (diarrhea-predominant)

Get alerted when new IBS-D (diarrhea-predominant) trials appear

New drug trial aims to calm IBS-Related diarrhea and pain